General
Drug company hiked cost of baby medicine by 85,000%, denies any wrongdoing
 

Drug company hiked cost of baby medicine by 85,000%, denies any wrongdoing

Shared by:

 
Mallinckrodt Pharmaceuticals agreed to settle charges of anti-competitive practices by paying a USD100 million fine and allow a competitor to produce a similar medication related to Acthar gel - a lifesaving medication for infantile spasms and multiple sclerosis.
 
today.mims.com
 
23 Jan 2017 - General